title: [Corrigendum] Temozolomide-induced modification of the CXC chemokine network in experimental gliomas.
abstract: After the publication of the article, the authors noted an error. The changes are as follows: In the initial and published version of Fig. 5, the data relied on triplicates in both the control (SCR) and treated (siCXCL2)conditions. In fact, the experiments were carried out in tetraplicates. However, the cells in one of the control (SCR) replicates died for unknown reasons. Thus, the data are here presented as the means ± SEM calculated from triplicates in the SCR control condition and from tetraplicates in the siCXCL2 condition. Therefore, shown below is the corrected version of Fig. 5.
authors: Département de BioAnalyse et de Toxicologie Pharmaceutique, Laboratoire de Toxicologie, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), Brussels, Belgium.
authors: Céline
authors: C
authors: Bruyère
authors: Tatjana
authors: T
authors: Mijatovic
authors: Caroline
authors: C
authors: Lonez
authors: Sabine
authors: S
authors: Spiegl-Kreinecker
authors: Walter
authors: W
authors: Berger
authors: Richard
authors: R
authors: Kast
authors: Jean-Marie
authors: JM
authors: Ruysschaert
authors: Laboratoire de Toxicologie, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), Campus de la Plaine, CP205/1, Boulevard du Triomphe, 1050 Brussels, Belgium.
authors: Robert
authors: R
authors: Kiss
authors: Florence
authors: F
authors: Lefranc